Autres langues AtriCure, Inc.

Actions

ATRC

US04963C2098

Equipement, fournitures et distribution médicale

Marché Fermé - Nasdaq 22:00:00 25/09/2026			Varia. 5j.	Varia. 1 janv.
58,38 ^USD	-3,93%		+0,48%	+47,57%

24/09	Un initié d’Atricure a vendu des actions pour un montant de 271 140 dollars, selon un récent dépôt auprès de la SEC	MT
04/09	Un dirigeant d'Atricure cède des actions pour une valeur de 407 558 $, selon un récent dépôt auprès de la SEC	MT

Autres langues

24/09	Atricure Insider Sold Shares Worth $271,140, According to a Recent SEC Filing
21/09	AtriCure, Inc.(NasdaqGM:ATRC) added to S&P 1000
21/09	AtriCure, Inc.(NasdaqGM:ATRC) added to S&P 600 Health Care
21/09	AtriCure, Inc.(NasdaqGM:ATRC) added to S&P Composite 1500
21/09	AtriCure, Inc.(NasdaqGM:ATRC) added to S&P 600
04/09	Atricure Insider Sold Shares Worth $407,558, According to a Recent SEC Filing
26/08	Atricure Insider Sold Shares Worth $458,099, According to a Recent SEC Filing
25/08	AtriCure to Participate in the 2026 Wells Fargo Health Care Conference
30/07	Atricure Insider Sold Shares Worth $946,000, According to a Recent SEC Filing
27/07	Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Michael H. Carrel to its Board of Directors
27/07	AtriCure to Participate at Upcoming Investor Conferences
23/07	AtriCure Q2 Swings to Adjusted Earnings, Revenue Rises
23/07	(ATRC) AtriCure Expects 2026 Adjusted EPS Range $0.24-$0.32, vs. FactSet Est of $0.12
23/07	(ATRC) AtriCure Expects 2026 Revenue Range $602M-$610M, vs. FactSet Est of $604.6M
23/07	AtriCure: Q2 Earnings Snapshot
23/07	Earnings Flash (ATRC) AtriCure, Inc. Reports Q2 Revenue $153.6M, vs. FactSet Est of $151.8M
23/07	Earnings Flash (ATRC) AtriCure, Inc. Posts Q2 Adjusted EPS $0.18 per Share, vs. FactSet Est of $0.00
23/07	AtriCure Reports Second Quarter 2026 Financial Results
23/07	AtriCure, Inc. Provides Earnings Guidance for the Full Year 2026
23/07	AtriCure, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
02/07	AtriCure to Announce Second Quarter 2026 Financial Results
29/06	AtriCure, Inc.(NasdaqGM:ATRC) added to Russell 2000 Defensive Index
29/06	AtriCure, Inc.(NasdaqGM:ATRC) added to Russell 2000 Growth-Defensive Index
27/05	AtriCure to Participate in the Goldman Sachs 47th Annual Global Health Care Conference
08/05	AtriCure : Investor Presentation Q1 2026 vF